Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - SHORT-TERM DEBT
Short-term Debt ALNY - Alnylam Pharmaceuticals, Inc.
41.9 M
LAST VALUE
-28.64%
2 YEAR CAGR
8.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR